Pro-Dex (NASDAQ:PDEX) vs. Vycor Medical (OTCMKTS:VYCO) Critical Survey

Vycor Medical (OTCMKTS:VYCO) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Institutional and Insider Ownership

15.3% of Pro-Dex shares are owned by institutional investors. 42.6% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Vycor Medical and Pro-Dex’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vycor Medical	$1.46 million	2.01	-$70,000.00	N/A	N/A
Pro-Dex	$46.09 million	1.33	$7.07 million	$0.58	30.91

Pro-Dex has higher revenue and earnings than Vycor Medical.

Profitability

This table compares Vycor Medical and Pro-Dex’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vycor Medical	-7.49%	N/A	-10.32%
Pro-Dex	4.13%	6.50%	4.01%

Risk and Volatility

Vycor Medical has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Vycor Medical and Pro-Dex, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vycor Medical	0	0	0	0	N/A
Pro-Dex	0	0	0	0	N/A

Summary

Pro-Dex beats Vycor Medical on 7 of the 9 factors compared between the two stocks.

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

About Pro-Dex

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.